Qiaohan Xu

MMsc of Biomedical Informatics student at Harvard Medical School

Portland, Oregon, United States

About

Neuroscience major with computer science minor graduating in January 2025, with an interest in bioinformatics. Previous research experiencing including scRNA data analysis, refining genomics pipeline, and molecular dynamic modeling.

Experience

  • Graduate Student Research Assistant at Dana-Farber Cancer Institute
    Nov 2025 - Present · 8 mos

  • Research Lab Tech I at Mass General Brigham
    Feb 2025 - Feb 2026 · 1 yr 1 mo

  • Reed College (3 yrs 6 mos)
    • Interconnect Mentor
      May 2023 - Feb 2026 · 2 yrs 10 mos

      • Hosted International Student Orientation for 50+ incoming international students with diverse background. • Mentored 7 international students by scheduling one-on-one meetings and monthly group events. Provided emotional support and suggestions on transition to a foreign institution.

    • Topics in Biology Learning Assistant
      Sep 2022 - May 2024 · 1 yr 9 mos

      • Assisted department associates with lab preparation of the year-long course “Topics in Biology” for 150+ students. • Assisted weekly lab section with 15 students, facilitated group discussions and evaluated student understandings. • Held monthly study groups and weekly office hours.

    • Academic Year Research Assistant
      Oct 2023 - Jan 2024 · 4 mos

      Project: Molecular dynamic simulation on protein interaction • To better understand the mechanism and conditions for liquid-liquid phase separation, performed simulation on protein interaction using hydrophobicity scale (HPS) model and umbrella sampling. • Plan on extending to real sequences by changing residue types and/or charge sequencing.

  • Research Assistant at Mass General Brigham
    May 2024 - Sep 2024 · 5 mos

  • Research Assistant at Oregon Health & Science University
    Sep 2023 - Apr 2024 · 8 mos

    Project: Transcriptomic Change between pre-puberty and DCIS-stage C3(1)-Tag mice • PARP inhibitor treatment effectively treats triple negative breast cancer, but the specific mechanism remains unknown. • To investigate the therapeutic effect of PARP inhibitor on tumor microenvironment, performed cell clustering and cell-cell communication analysis on scRNAseq data obtained from pre-puberty and DCIS-stage C3(1)-Tag mice, which serves as a benchmark of further analysis.